Journals / Türk Kardiyoloji Derneği Arşivi / 2014 / Cilt: 42 - Sayı: 3

Gama-glutamil transferaz enziminin akut koroner sendroma bağlı sol venrikül sistolik fonksiyon bozukluğu gelişen hastalarda yeni başlangıçlı kalp yetersizliğini öngörmede yararı

Usefulness of admission gamma-glutamyltransferase level for predicting new-onset heart failure in patients with acute coronary syndrome with left ventricular systolic dysfunction

Pages
236–244
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Increased admission GGT level in acute coronary syndrome with heart failure should be monitored closely and treated aggressively.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Our aim was to determine whether there is a relationship between admission gamma-glutamyltransferase (GGT) and subsequent heart failure hospitalizations in pa- tients with acute coronary syndrome.
📊
Key Findings & Data:Study design: We selected 123 patients with newly diag- nosed acute coronary syndrome of ejection fraction (EF) 49 IU/L on admission, presence of hyper- tension and hyperlipidemia, left ventricular ejection fraction (LVEF), right ventricular dysfunction, moderate-to-severe mitral regurgitation, alanine aminotransferase level, and antiplatelet agent usage were found to have prognostic sig- nificance in univariate Cox proportional hazards analysis.
💡
Conclusion & Impact:Increased admission GGT level in acute coronary syndrome with heart failure should be monitored closely and treated aggressively.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Our aim was to determine whether there is a relationship between admission gamma-glutamyltransferase (GGT) and subsequent heart failure hospitalizations in pa- tients with acute coronary syndrome. Study design: We selected 123 patients with newly diag- nosed acute coronary syndrome of ejection fraction (EF) 49 IU/L on admission, presence of hyper- tension and hyperlipidemia, left ventricular ejection fraction (LVEF), right ventricular dysfunction, moderate-to-severe mitral regurgitation, alanine aminotransferase level, and antiplatelet agent usage were found to have prognostic sig- nificance in univariate Cox proportional hazards analysis. In multivariate Cox proportional-hazards model, increased GGT >49 IU/L on admission (hazard ratio [HR] 2.663, p=0.047), presence of hypertension (HR 4.107, p=0.007), and LVEF (HR 0.911, p=0.002) were found to be independent factors to predict new-onset heart failure requiring hospitalization. Conclusion: Hospitalization in heart failure was associated with increased admission GGT levels. Increased admission GGT level in acute coronary syndrome with heart failure should be monitored closely and treated aggressively.

Özet

Amaç: Çalışmamızın amacı akut koroner sendrom nedeniyle hastaneye kabul sırasındaki gama-glutamil transferaz (GGT) düzeyleri ile kalp yetersizliği nedeniyle hastaneye yatışlar arasında ilişki olup olmadığını araştırmaktır.Çalışma planı: Çalışmaya akut koroner sendrom ile başvurup ejeksiyon fraksiyonu (EF) %45in altında olan 123 hasta alındı. Hastalar 15±10 ay takip edildi. Hastaların kabul sırasındaki GGT düzeyleri ile izleme süresinde kalp yetersizliği nedeniyle hastaneye yatışları arasındaki ilişki incelendi.Bulgular: İzleme süresi olan 15±10 ay içinde 23 hasta (%18.7) kalp yetersizliğine bağlı olarak hastaneye yatırıldı. ROC (receiver operating characteristics) eğrisi analizi yöntemi ile hastaneye yatışı öngördüren GGT kesim değeri 49 IU/L olarak saptandı (%81.7 duyarlılık ve %65.2 özgüllük). Tek değişkenli Cox orantısal risk analizinde, GGT düzeyinin >49 IU/L olması, hipertansiyon ve hiperlipidemi, sol ventrikül ejeksiyon fraksiyonu (SVEF), orta-ciddi mitral yetersizliği varlığı, alanin aminotransferaz seviyesi ve antitrombosit ilaç kullanımı anlamlı bulundu. Çok değişkenli Cox orantısal risk modelinde, kalp yetersizliği nedeniyle hastaneye yatış ile ilişkili bağımsız risk faktörleri olarak ilk kabul sırasında GGT >49 olması (risk oranı [RO] 2.663, p=0.047), hipertansiyon varlığı (RO 4.107, p=0.007) ve SVEF (RO 0.911, p=0.002) parametreleri saptandı.Sonuç: Akut koroner sendromlu hastalarda kabul GGT düzeyleri takipte kalp yetersizliğine bağlı hastaneye yatışlar ile ilişkilidir. Bu hastalar daha yakın takip edilmeli ve tedavileri optimal düzeyde ayarlanmalıdır.

🔖

Cite This Article

KAYA, H., AYDIN, G., YILDIRIMLI, K., BAŞARAN, A., ZORLU, A., BULUT, M., AKYOL, L., ŞAHİN, Ş., YÜCEL, H., SARIKAYA, S. (2022). Gama-glutamil transferaz enziminin akut koroner sendroma bağlı sol venrikül sistolik fonksiyon bozukluğu gelişen hastalarda yeni başlangıçlı kalp yetersizliğini öngörmede yararı. Türk Kardiyoloji Derneği Arşivi, Cilt: 42 - Sayı: 3, 236–244. https://ajindex.com/articles/632483

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Braunwald E. Biomarkers in heart failure. N Engl J Med 2008
  2. CrossRef 2. Mason JE, Starke RD, Van Kirk JE. Gamma-glutamyl transferase: a novel cardiovascular risk biomarker. Prev Cardiol 2010
  3. CrossRef 3. Ryu S, Chang Y, Kim DI, Kim WS, Suh BS. Gamma-Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Clin Chem2007
  4. CrossRef 4. Paolicchi A, Emdin M, Passino C, Lorenzini E, Titta F, Marchi S, et al. Beta-lipoprotein- and LDL-associated serum gammaglutamyltransferase in patients with coronary atherosclerosis. Atherosclerosis 2006
  5. CrossRef 5. Sacchetti L, Castaldo G, Fortunato G, Salvatore F. Improved procedure for measuring gamma-glutamyltransferase isoenzymes in serum. Clin Chem 1988
  6. Lee DH, Silventoinen K, Hu G, Jacobs DR Jr, Jousilahti P, Sundvall J, et al. Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women. Eur Heart J 2006
  7. CrossRef 7. Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H
  8. Vorarlberg Health Monitoring and Promotion Program Study Group. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 2005
  9. CrossRef 8. Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, et al. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2007
  10. Meisinger C, Döring A, Schneider A, Löwel H
  11. KORA Study Group. Serum gamma-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population. Atherosclerosis 2006
  12. CrossRef 10. Bots ML, Salonen JT, Elwood PC, Nikitin Y, Freire de Concalves A, Inzitari D, et al. Gamma-glutamyltransferase and risk of stroke: the EUROSTROKE project. J Epidemiol Community Health 2002
  13. 56 Suppl 1:i25-9. CrossRef 11. Lee DH, Buijsse B, Steffen L, Holtzman J, Luepker R, Jacobs DR Jr. Association between serum gamma-glutamyltransferase and cardiovascular mortality varies by age: the Minnesota Heart Survey. Eur J Cardiovasc Prev Rehabil 2009
  14. Fraser A, Harris R, Sattar N, Ebrahim S, Smith GD, Lawlor DA. Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the